Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5867 Articles

Paul Ausick | Jan 11, 2012 at 1:37 PM EST

Pharma Value Beyond The Patent Expiration Cliff (PFE, MRK, BMY, TEVA, AMGN, GSK)

The tide of patent expirations that is washing over big pharmaceutical houses is cresting now and investors have begun looking…

Jon C. Ogg | Jan 10, 2012 at 11:47 AM EST

The $1,000 Genome Finally Arrives (LIFE)

Personalized medicine is coming… if you can afford it. The quest for the $1,000 genomic map has been a race and…

Douglas A. McIntyre | Jan 10, 2012 at 6:53 AM EST

It Takes a Recession to Slow U.S. Health Care Cost Increases

It takes a recession to slow what has normally been runaway U.S. health care costs. The trend may be part of a…

Douglas A. McIntyre | Jan 6, 2012 at 6:39 AM EST

Short Sellers Help Push Dendreon Higher

Dendreon (NASDAQ: DNDN) soared almost 40% in value, or $3.02 a share, in active trading on Thursday after announcing that…

Jon C. Ogg | Jan 5, 2012 at 11:09 AM EST

How Dendreon’s Good News Could Spread Around Biotech (DNDN, HGSI, IBB, FBT)

Dendreon Corporation (NASDAQ: DNDN) is living up to something we showed late in December. It was one of the Top…

Jon C. Ogg | Jan 4, 2012 at 8:01 AM EST

Tracking Dividends in Biotech: Who Follows Amgen in Payouts? (AMGN, PFE, MRK, BIIB, CELG, ALXN, CBST, PDLI, REGN, VRTX)

For several years it has been the case that Amgen Inc. (NASDAQ: AMGN) was considered a biotech though it had at…

Jon C. Ogg | Dec 28, 2011 at 7:01 AM EST

Top Biotech Stock Picks For 2012 (ARIA, DNDN, GILD, HGSI, ILMN, INCY, JAZZ, LIFE, THRX, IBB, XBI)

The biotech sector has seen its share of ups and downs in 2011 and prior years. It is almost always…

Jon C. Ogg | Dec 22, 2011 at 11:18 AM EST

Small Caps With Over 50% Stock Upside in 2012 (PNK, CDXS, VVUS, SCMR)

Over the last week we have been reviewing some of the “Small Cap Stocking Stuffers” that features the top small…

Jon C. Ogg | Dec 21, 2011 at 5:06 PM EST

Top Med-Tech Stock Picks for 2012 (BSX, ISRG, STJ)

Many research firms have been coming up with their best ideas lists for 2012. Today brought a list of top…

Jon C. Ogg | Dec 15, 2011 at 9:54 AM EST

ARIAD Secures Much-Needed Capital for Trials, Commercialization, and Growth (ARIA)

ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) is raising cash to help support the commercialization of ponatinib in patients with resistant or…

Jon C. Ogg | Dec 15, 2011 at 7:58 AM EST

SonoSite, Some Rumored Mergers Come True (SONO)

Some rumors surrounding the world of mergers and acquisitions actually do manage to come true. The newest deal to hit the…

Jon C. Ogg | Dec 12, 2011 at 9:04 AM EST

The ‘Double’ Call in Human Genome (HGSI)

Human Genome Sciences Inc. (NASDAQ: HGSI) is not getting much of a boost despite being called as stock which could…

Jon C. Ogg | Dec 8, 2011 at 11:14 AM EST

Get Ready for a Pfizer Dividend Hike… A Holiday Gift From Big Pharma (PFE, MRK, WPI, TEVA)

We recently gave a full review of the DJIA components we expect to raise their dividend payouts in the weeks…

Jon C. Ogg | Dec 6, 2011 at 12:45 PM EST

Dendreon Raising $125 Million Via I.P. Sale (DNDN, MRK)

AuthorDendreon Corporation (NASDAQ: DNDN) is supposed to be the king of prostate cancer with its PROVENGE treatment. Unfortunately, PROVENGE sales…

Jon C. Ogg | Nov 29, 2011 at 11:28 AM EST

Winners as Pfizer Loses Lipitor Patent (PFE, TEVA, MYL, WPI)

Pfizer Inc. (NYSE: PFE) has a big day ahead of it. While it has been known for years, it is…

1 … 323 324 325 326 327 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Pharma Value Beyond The Patent Expiration Cliff (PFE, MRK, BMY, TEVA, AMGN, GSK)

The $1,000 Genome Finally Arrives (LIFE)

It Takes a Recession to Slow U.S. Health Care Cost Increases

Short Sellers Help Push Dendreon Higher

How Dendreon’s Good News Could Spread Around Biotech (DNDN, HGSI, IBB, FBT)

Tracking Dividends in Biotech: Who Follows Amgen in Payouts? (AMGN, PFE, MRK, BIIB, CELG, ALXN, CBST, PDLI, REGN, VRTX)

Top Biotech Stock Picks For 2012 (ARIA, DNDN, GILD, HGSI, ILMN, INCY, JAZZ, LIFE, THRX, IBB, XBI)

Small Caps With Over 50% Stock Upside in 2012 (PNK, CDXS, VVUS, SCMR)

Top Med-Tech Stock Picks for 2012 (BSX, ISRG, STJ)

ARIAD Secures Much-Needed Capital for Trials, Commercialization, and Growth (ARIA)

SonoSite, Some Rumored Mergers Come True (SONO)

The ‘Double’ Call in Human Genome (HGSI)

Get Ready for a Pfizer Dividend Hike… A Holiday Gift From Big Pharma (PFE, MRK, WPI, TEVA)

Dendreon Raising $125 Million Via I.P. Sale (DNDN, MRK)

Winners as Pfizer Loses Lipitor Patent (PFE, TEVA, MYL, WPI)

‘You Bought Stupid Cars You Can’t Afford. You Didn’t Buy a Stupid House.’: Dave Ramsey to Spokane Caller Sitting on $900K Inherited Home and $100K in Debt

This $575,000 Portfolio Pays More Cash Every Month Than $1 Million in the S&P 500

How a 52-Year-Old Can Turn $425,000 Into a Monthly Paycheck Machine by 62

'You Bought Stupid Cars You Can't Afford. You Didn't Buy a Stupid House.': Dave Ramsey to Spokane Caller Sitting on $900K Inherited Home and $100K in Debt

This $575,000 Portfolio Pays More Cash Every Month Than $1 Million in the S&P 500

‘You Bought Stupid Cars You Can’t Afford. You Didn’t Buy a Stupid House.’: Dave Ramsey to Spokane Caller Sitting on $900K Inherited Home and $100K in Debt

This $575,000 Portfolio Pays More Cash Every Month Than $1 Million in the S&P 500

Health and Healthcare Articles

All Health and Healthcare Articles

Pharma Value Beyond The Patent Expiration Cliff (PFE, MRK, BMY, TEVA, AMGN, GSK)

The $1,000 Genome Finally Arrives (LIFE)

It Takes a Recession to Slow U.S. Health Care Cost Increases

Short Sellers Help Push Dendreon Higher

How Dendreon’s Good News Could Spread Around Biotech (DNDN, HGSI, IBB, FBT)

Tracking Dividends in Biotech: Who Follows Amgen in Payouts? (AMGN, PFE, MRK, BIIB, CELG, ALXN, CBST, PDLI, REGN, VRTX)

Top Biotech Stock Picks For 2012 (ARIA, DNDN, GILD, HGSI, ILMN, INCY, JAZZ, LIFE, THRX, IBB, XBI)

Small Caps With Over 50% Stock Upside in 2012 (PNK, CDXS, VVUS, SCMR)

Top Med-Tech Stock Picks for 2012 (BSX, ISRG, STJ)

ARIAD Secures Much-Needed Capital for Trials, Commercialization, and Growth (ARIA)

SonoSite, Some Rumored Mergers Come True (SONO)

The ‘Double’ Call in Human Genome (HGSI)

Get Ready for a Pfizer Dividend Hike… A Holiday Gift From Big Pharma (PFE, MRK, WPI, TEVA)

Dendreon Raising $125 Million Via I.P. Sale (DNDN, MRK)

Winners as Pfizer Loses Lipitor Patent (PFE, TEVA, MYL, WPI)

‘You Bought Stupid Cars You Can’t Afford. You Didn’t Buy a Stupid House.’: Dave Ramsey to Spokane Caller Sitting on $900K Inherited Home and $100K in Debt

This $575,000 Portfolio Pays More Cash Every Month Than $1 Million in the S&P 500

How a 52-Year-Old Can Turn $425,000 Into a Monthly Paycheck Machine by 62

Featured Reads

'You Bought Stupid Cars You Can't Afford. You Didn't Buy a Stupid House.': Dave Ramsey to Spokane Caller Sitting on $900K Inherited Home and $100K in Debt

This $575,000 Portfolio Pays More Cash Every Month Than $1 Million in the S&P 500